PRLAX
Price
$19.88
Change
-$0.09 (-0.45%)
Updated
Jul 25 closing price
Net Assets
364.07M
SLAFX
Price
$31.25
Change
-$0.21 (-0.67%)
Updated
Jul 25 closing price
Net Assets
271.3M
Interact to see
Advertisement

PRLAX vs SLAFX

Header iconPRLAX vs SLAFX Comparison
Open Charts PRLAX vs SLAFXBanner chart's image
T. Rowe Price Latin America
Price$19.88
Change-$0.09 (-0.45%)
VolumeN/A
Net Assets364.07M
DWS Latin America Equity S
Price$31.25
Change-$0.21 (-0.67%)
VolumeN/A
Net Assets271.3M
PRLAX vs SLAFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PRLAX vs. SLAFX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRLAX is a StrongBuy and SLAFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRLAX has more cash in the bank: 364M vs. SLAFX (271M). SLAFX pays higher dividends than PRLAX: SLAFX (4.01) vs PRLAX (2.78). PRLAX was incepted earlier than SLAFX: PRLAX (32 years) vs SLAFX (33 years). PRLAX (1.46) is less costly to investors than SLAFX (1.33). SLAFX is a more actively managed with annual turnover of: 101.00 vs. PRLAX (23.20). PRLAX (2500) and SLAFX (2500) have matching initial minimum investment requirements. SLAFX annual gain was more profitable for investors over the last year : 12.83 vs. PRLAX (5.60). SLAFX return over 5 years is better than : 42.65 vs. PRLAX (18.99).
PRLAXSLAFXPRLAX / SLAFX
Total Expense Ratio1.461.18124%
Annual Report Gross Expense Ratio1.461.33110%
Fund Existence32 years33 years-
Gain YTD22.48928.65478%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets364M271M134%
Annual Yield % from dividends2.784.0169%
Returns for 1 year5.6012.8344%
Returns for 3 years33.4940.2283%
Returns for 5 years18.9942.6545%
Returns for 10 years26.28109.2324%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IYMIX31.450.32
+1.03%
Macquarie Mid Cap Growth I
GMVIX16.740.15
+0.90%
Goldman Sachs Small/Mid Cap Equity Inv
MLPSX90.170.51
+0.57%
ProFunds Mid Cap Value Svc
PHSZX42.460.21
+0.50%
PGIM Jennison Health Sciences Z
AQGRX12.550.02
+0.16%
AQR Global Equity R6